In vitro and in vivo inhibition of rat brain nitric oxide synthase activity by phencyclidine

International Journal of Toxicology

Volumn 18, Issue 4, 1999, Pages 245-250

  Desaiah, D ^a,d   Pande, M ^a   Vig, P J S ^a   Cameron, J A ^b   Ali, S F ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Jackson State University   (United States)

^c Natl Ctr Toxicological Res F   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Brain; Nitric Oxide Synthase; Phencyclidine

Indexed keywords

ARGININE; CITRULLINE; NITRIC OXIDE SYNTHASE; PHENCYCLIDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BRAIN LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE COMPLEX; MALE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; QUANTITATIVE DIAGNOSIS; RAT;

ANIMALIA;

EID: 0032841233     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225396     Document Type: Article

References (34)

1. Albuquerque, E. X., L. G. Aguayo, J. E. Warnick, H. Weinstein, S. D. Click, S. Maayani, R. K. Ickowicz, and M. P. Blaustein. 1981. The behavioral effects of phencyclidines may be due to their blockade of potassium channels. Proc. Natl. Acad. Sci. U.S.A. 78:7792-7796.
2. Ali, S. F., R. R. Holson, E. D. Newport, W. Slikker Jr, and J. F. Bowyer. 1993. Development of dopamine and N-methyl-D-aspartate systems in rat brain: The effect of prenatal phencyclidine exposure. Dev. Brain Res. 73:25-33.
3. Aniline, O., and G. M. Simpson. 1979. Psychiatric aspects of phencyclidine. In Advances in neurotoxicology, ed. L. Manzo, 27-30. New York: Pergamon Press.
4. Bohme, G. A., C. Bon, M. Lemire, M. Reiband, O. Piot, J. M. Stutzman, and J. C. Doble. 1993. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor treated rats. Proc. Natl. Aca. Sci. U.S.A. 90:9191-9194.
5. Bowyer, J. R., K. P. Spuhler, and N. Weiner. 1984. Effects of phencyclidine, amphetamine and related compounds in dopamine release from striatal slices. J. Pharmacol. Exp. Ther. 257:262-270.
6. Bredt, D. S., and S. H. Snyder. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87:682-685.
7. Demas, G. E., M. J. Eliasson, T. M. Dawson, V. L. Dawson, L. J. Kriegsfield, R. L. Nelson, and S. H. Snyder. 1997. Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice. Mol. Med. 3:610-616.
8. Domino, E. F., and E. D. Luby. 1981. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In PCP (phencyclidine): Historical and current perspectives, ed. E. F. Domino, 401-418. Ann Arbor, MI: NPP Books.
9. 3H]Phencyclidine interactions with the nicotonic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic and viral and antiarrythmic drugs. Mol. Pharmacol. 22: 72-81.
10. Ffrench-Mullen, J. M. H., and M. A. Rogawski. 1992. Phencyclidine block of calcium current in isolated guinea pig hippocampal neurons. J. Physiol. 456:85-105.
11. Furchgott, R. F. 1990. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol. Scan. 139:257-270.
12. Gao, X. M., and C. A. Tamminga. 1996. Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48 hour time course. Synapse 23:274-279.
13. Garthwaite, J. G. 1991. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:60-67.
14. Garthwaite, J., S. L. Charles, and R. Chess-Williams. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature 336:385-388.
15. Ignarro, L. J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann. Rev. Pharmacol. Toxicol. 30:535-560.
16. Jewett, D. C., E. R. Butelman, and J. H. Woods. 1996. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Res. 715:25-31.
17. Johansson, C., D. M. Jackson, and L. Svensson. 1997. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioral effects on prepulse inhibition and locomotor activity. Psychopharmacology 131:167-173.
18. Johnson, K. M., and S. M. Jones. 1990. Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Ann. Rev. Pharmacol. Toxicol. 30:707-750.
19. Joshi, P., P. J. S. Vig, V. Veerisetty, J. A. Cameron, B. S. Sekhon, and D. Desaiah. 1996. Increase in brain nitric oxide synthase activity in daunorubicine-treated rats. Pharmacol. Toxicol. 78:99-103.
20. Karson, C. N., W. S. Griffin, R. E. Mrak, M. Husain, T. M. Dawson, S. H. Snyder, N. C. Moore, and W. Q. Stumer. 1996. Nitric oxide synthase (NOS) in schizophrenia increases in cerebellar vermis. Mol. Chem. Neuropathol. 27:275-284.
21. Lineweaver, H., and D. Burk. 1934. Determination of enzyme dissociation constants. J. Am. Chem. Soc. 56:6589-6666.
22. Marietta, M. A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12231-12234.
23. Mattson, M. P., B. Rychlik, and B. Cheng. 1992. Degenerative and axon outgrowth - altering effects of phencyclidine in human fetal cerebral cortical cells. Neuropharmacology 51:279-291.
24. Mattson, M. P., B. Rychlik, J. S. You, and J. S. Sisken. 1991. Sensitivity of cultured human embryonic cerebral cortical neurons to excitatory amino acid-induced calcium influx and neurotoxicity. Brain Res. 42:97-106.
25. Moncada, S., R. M. J., Palmer, and E. A. Higgs. 1989. Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38:1709-1715.
26. Nabeshima, T., S. P. Sivam, J. C. Norris, and I. K. Ho. 1981. Calcium-dependent GABA release from mouse brain slices following acute and chronic phencyclidine administration. Res. Commun. Subst. Abuse 2:343-354.
27. Nabeshima, T., K. Yamaguchi, M. Hiramatsu, M. Amano, I. Pumkawa, and I. Kanneyama. 1984. Serotonergic involvement in phencyclidine-induced behaviors. Pharmacol. Biochem. Behav. 21:401-408.
28. Osawa, Y., and J. C. Davila. 1993. Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem. Biophys. Res. Commun. 194:1435-1339.
29. Pande, M., J. A., Cameron, P. J. S. Vig, S. F. Ali, and D. Desaiah. 1999. Inhibition of calcium ATPase by phencyclidine in rat brain. Mol. Cell. Biochem. In press.
30. Rasmussen, H., and P. G. Barren. 1984. Calcium messenger system: An integrated view. Physiol. Rev. 64:938-984.
31. 2+ ATPase. J. Biochem. Toxicol. 1:55-66.
32. Sircar, R., P. Follesa, and M. K. Ticku. 1996. Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex. Mol. Brain Res. 40:214-220.
33. Snyder, S. H., and D. S. Bredt. 1992. Biological roles of nitric oxide. Sci. Am. 266:68-71.
34. Zhang, J., and S. H. Snyder. 1995. Nitric oxide in the nervous system. Ann. Rev. Pharmacol. Toxicol. 35:213-233.